李登宝, 谷江, 陈方敏, 石家齐, 赵卓飞, 施刚, 赵高贤. 膀胱癌肉瘤(附3例报告)[J]. 中国肿瘤临床, 2008, 35(2): 75-77.
引用本文: 李登宝, 谷江, 陈方敏, 石家齐, 赵卓飞, 施刚, 赵高贤. 膀胱癌肉瘤(附3例报告)[J]. 中国肿瘤临床, 2008, 35(2): 75-77.
LI Dengbao, GU Jiang, CHEN Fangmin, SHI Jiaqi, ZHAO Zhuofei, SHI Gang, ZHAO Gaoxian. Bladder Carcinosarcoma (Report of 3 cases)[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 35(2): 75-77.
Citation: LI Dengbao, GU Jiang, CHEN Fangmin, SHI Jiaqi, ZHAO Zhuofei, SHI Gang, ZHAO Gaoxian. Bladder Carcinosarcoma (Report of 3 cases)[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 35(2): 75-77.

膀胱癌肉瘤(附3例报告)

Bladder Carcinosarcoma (Report of 3 cases)

  • 摘要: 目的: 探讨膀胱癌肉瘤的临床特征、病理特点及诊治。 方法: 对2002年1月~2006年9月收治的3例膀胱癌肉瘤患者的临床资料进行复习,并结合文献进行讨论。 结果: 3例患者均为男性,临床表现以无痛性肉眼血尿或尿频为主要症状。B超或CT示膀胱占位。膀胱镜检示膀胱肿瘤1例。2例患者行膀胱部分切除术,1例患者行膀胱全切术及盆腔淋巴结清扫术。2例术后辅以化疗。术后病理检查可见肿瘤由上皮和间质两种恶性成分组成,均诊断为膀胱癌肉瘤。1例免疫组织化学检查CK(-)、LCA(-)、CD20(-)、CD45_Ro(-)、NSE(-)、Myo(++)、CgA(-)、Syn(-)、Vim(-)、Des(-);1例免疫组织化学检查Vim(++)、CK(++)、Des(-)、Actin(-)、CD68(++)、S-100(-)、MyoD1(-)、Myo-genin(-)、SMA(-)。1例术后随访30个月死于肺、肝转移,1例术后随访8个月死于肺转移,另1例则失访。 结论: 膀胱癌肉瘤是一种临床罕见的恶性肿瘤,生物学行为独特,恶性程度高,浸润性强,进展迅速,预后差。确诊依靠病理组织学和免疫组织化学检查。尽早行根治性膀胱切除术是最佳治疗方法。

     

    Abstract: Objective: To evaluate the clinical and pathological features of bladder carcinosarcoma and its diagnosis and treatment. Methods: The clinical data from 3 patients with bladder carcinosarcoma treated from January 2002 to September 2006 were analyzed and the related literatures were reviewed. Results: The 3 cases were all male and the age was 60, 36 and 13 years old, respectively. The most common symptoms were painless gross hematuria or pollakisuria. Bultrasound or CT showed masses of the bladder. Cystoscopy showed bladder tumor in 1 patient. Partial resection was performed in 2 patients. Radical cystectomy and pelvic lymph node dissection were performed in 1 patient. Chemotherapy was given to 2 patients after surgery. Pathological examination revealed that the tumors were composed of epithelium and mesenchyme and were diagnosed as bladder carcinosarcoma. Immunohistochemistry showed positive expression of Myo and negative expression of CK, LCA, CD20, CD45Ro, NSE, CgA, Syn, Vim and Des in tumor tissues of 1 patient and positive expression of Vim, CD68 and CK and negative expression of Des, Actin, S-100, MyoD1, Myogenin and SMA in another patient's tumor tissues. One patient died of lung and liver metastasis 30 months after surgery, another died of lung metastasis 8 months after surgery and the other one was failed to be followed-up. Conclusion: Bladder carcinosarcoma is a rare malignant tumor, with high malignancy, strong ability to infiltrate, rapid progression and poor prognosis. The diagnosis depends on pathology and immunohistochemistry. Early radical cystectomy is the best treatment.

     

/

返回文章
返回